Advertisement
Advertisement
July 28, 2020
Cerus Endovascular Receives CE Mark Approval for the CerusEndo MC 021 Microcatheter
July 28, 2020—Cerus Endovascular Ltd. announced that it has received CE Mark approval for its CerusEndo MC 021 microcatheter, which is designed to access tortuous neurovasculature and deliver therapeutic devices to intended targets. The company expects to begin commercial sales across the European Union during Q4 2020.
The CerusEndo MC 021 microcatheter will be available in multiple distal flexible profiles and is designed to offer superior proximal support for enhanced deliverability and responsiveness in physicians’ hands. In February 2020, the company announced FDA approval for the device.
Advertisement
Advertisement